BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 226 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $226,000 | -6.2% | 1,497 | -9.6% | 0.00% | 0.0% |
| Q2 2022 | $241,000 | -9.7% | 1,656 | -26.6% | 0.00% | 0.0% |
| Q1 2022 | $267,000 | -14.7% | 2,256 | -0.7% | 0.00% | 0.0% |
| Q4 2021 | $313,000 | +8.3% | 2,271 | +9.0% | 0.00% | 0.0% |
| Q3 2021 | $289,000 | +36.3% | 2,083 | -4.4% | 0.00% | – |
| Q2 2021 | $212,000 | -44.2% | 2,180 | -68.8% | 0.00% | -100.0% |
| Q4 2019 | $380,000 | +31.9% | 6,979 | +1.2% | 0.00% | 0.0% |
| Q3 2019 | $288,000 | -5.9% | 6,895 | -1.4% | 0.00% | 0.0% |
| Q2 2019 | $306,000 | -22.7% | 6,995 | -9.1% | 0.00% | -50.0% |
| Q1 2019 | $396,000 | +40.4% | 7,699 | +1.0% | 0.00% | +100.0% |
| Q4 2018 | $282,000 | -1.4% | 7,624 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $286,000 | -1.7% | 7,624 | +3.4% | 0.00% | 0.0% |
| Q2 2018 | $291,000 | – | 7,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
| Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
| Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |